Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21)

Application Due Date: 2013-01-07  |  Post Date: 2009-11-20  |  Funding Number: PA-10-023


    Interested in this funding opportunity? Sign Up for it! CLICK HERE TO SIGNUP -> Expand   

Link to Full Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-10-023.html

Description: Purpose. This Funding Opportunity Announcement (FOA) invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-024, that encourages applications under the NIH Exploratory/Developmental Phased Innovation (R21/R33) award mechanism and PA-08-137 that seeks applications using the Small Business Innovation Research (SBIR [R43/R44]) award mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Expected Number of Awards: Not Available
Estimated Total Program Funding: Not Available
Award Ceiling: 200000
Award Floor: None
Cost Sharing or Matching Requirement: N
CFDA Number: 93.242, 93.273, 93.279, 93.286, 93.866000000
Funding Instrument Type: G

Eligible Applicants:
State Governments
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other tha
Nonprofits that do not have a 501(c)(3) status with the IRS,
Private institutions of higher education
For profit organizations other than small businesses
Others